Chondrial Therapeutics' Debt Round

Chondrial Therapeutics raised a round of funding on June 06, 2014.

Chondrial Therapeutics is an emerging biotechnology company focused on the treatment of rare mitochondrial diseases. Chondrial's lead compound is CTI-1601, which the Company is developing as a potenti…

Articles about Chondrial Therapeutics' Debt Round: